Literature DB >> 8203465

A unique rat model of bile ductular hyperplasia in which liver is almost totally replaced with well-differentiated bile ductules.

A E Sirica1, S L Cole, T Williams.   

Abstract

A novel rat model was developed in which furan combined in a unique synergistic manner with bile duct ligation to induce replacement of most of liver with well-differentiated hyperplastic bile ductules. Multiple tissue sections of liver from Fischer 344 male rats first subjected to a bile duct ligation and 1 week later given furan by gavage at 45 mg/kg body weight, once a day, five times weekly for 5 to 6 weeks, exhibited a mean percent of bile ductule tissue per total liver section area of 72.6 +/- 16.3% compared to control values of 20.0 +/- 4.2% for bile duct-ligated rats that received corn oil by gavage instead of furan and 11.9 +/- 3.1% for rats that were given a sham operation followed by furan. This dramatic difference was also reflected by the very high mean gamma-glutamyl transpeptidase specific activity of liver homogenates from the bile duct-ligated/furan-treated rats, which was approximately 8 x 10(3) nmoles p-nitroaniline/mg protein/hour versus values of approximately 2 x 10(3) for bile duct-ligated/corn oil control, approximately 1 x 10(3) for sham-operated/furan-treated control, and 44.9 for untreated rat. The data presented support a potentially powerful experimental model for investigating bile ductular cell functions, differentiation, and proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8203465      PMCID: PMC1887473     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Biochemical characteristics of hyperplastic rat bile ductular epithelial cells cultured "on top" and "inside" different extracellular matrix substitutes.

Authors:  G A Mathis; S A Walls; A E Sirica
Journal:  Cancer Res       Date:  1988-11-01       Impact factor: 12.701

2.  Expression of multiple proteins structurally related to gamma-glutamyl transpeptidase in non-neoplastic adult rat hepatocytes in vivo and in culture.

Authors:  G A Mathis; P A Wyss; E G Schuetz; R P Hughey; A E Sirica
Journal:  J Cell Physiol       Date:  1991-02       Impact factor: 6.384

3.  Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat.

Authors:  P A Slott; M H Liu; N Tavoloni
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

4.  Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.

Authors:  J M Lemire; N Shiojiri; N Fausto
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

5.  Characterization of a primary bile ductular cell culture from the livers of rats during extrahepatic cholestasis.

Authors:  A E Sirica; C A Sattler; H P Cihla
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

6.  Origin and involution of hyperplastic bile ductules following total biliary obstruction.

Authors:  J A Gall; P S Bhathal
Journal:  Liver       Date:  1990-04

7.  Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.

Authors:  L W Elmore; A E Sirica
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

8.  Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats.

Authors:  L W Elmore; A E Sirica
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

9.  Intestinal metaplasia as a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene.

Authors:  M Tatematsu; T Kaku; A Medline; E Farber
Journal:  Lab Invest       Date:  1985-04       Impact factor: 5.662

10.  "Intestinal-type" of adenocarcinoma preferentially induced in right/caudate liver lobes of rats treated with furan.

Authors:  L W Elmore; A E Sirica
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701

View more
  8 in total

1.  Liver damage using suicide genes. A model for oval cell activation.

Authors:  M Bustos; B Sangro; P Alzuguren; A G Gil; J Ruiz; N Beraza; C Qian; A Garcia-Pardo; J Prieto
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Isolation and characterization of biliary epithelial cells from rainbow trout liver.

Authors:  J B Blair; G K Ostrander; M R Miller; D E Hinton
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

3.  Blast-like cell compartment in carcinogen-induced proliferating bile ductules.

Authors:  P M Novikoff; A Yam; I Oikawa
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

4.  A novel method for establishment and characterization of extrahepatic bile duct epithelial cells from mice.

Authors:  Chengwei Chai; Shuaiyu Zheng; Jiexiong Feng; Xiaojuan Wu; Jixin Yang; Mingfa Wei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-09-11       Impact factor: 2.416

5.  Expression of an intestine-specific transcription factor (CDX1) in intestinal metaplasia and in subsequently developed intestinal type of cholangiocarcinoma in rat liver.

Authors:  P Ren; D G Silberg; A E Sirica
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.

Authors:  A E Sirica; S Radaeva; N Caran
Journal:  Am J Pathol       Date:  1997-12       Impact factor: 4.307

7.  Ductular reaction after submassive necrosis in humans. Special emphasis on analysis of ductular hepatocytes.

Authors:  A J Demetris; E C Seaberg; A Wennerberg; J Ionellie; G Michalopoulos
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

8.  Ductular hepatocytes. Evidence for a bile ductular cell origin in furan-treated rats.

Authors:  A E Sirica; T W Gainey; V R Mumaw
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.